August 2020- SERIES: People living with HIV or AIDS are at increased risk of Hodgkin and non-Hodgkin lymphoma compared with HIV-negative individuals. Data on the risk of multiple myeloma or leukaemia are inconsistent and of low quality but the risk does not seem to be increased. Specific haematological malignancies occur in different contexts of age, … Read more
March 2020- COMMENTARY: As governments in sub-Saharan Africa (SSA) expand access to effective antiretroviral therapy (ART) for HIV-infected patients, cancer is becoming an increasingly important cause of preventable death in the region. According to the Global Burden of Disease study, cancer is now the second leading cause of death worldwide, and, despite decreases in cancer … Read more
Researchers at UNC Project Malawi and the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in … Read more
“Together Against Cancer” The UNC Project Cancer Program hosted its 3rd Annual Malawi Cancer Symposium on May 26th-27th, 2021. The symposium was organized by the UNC Project Malawi Cancer Program in collaboration with the Malawi Ministry of Health and with funding from the National Institute of Health. Due to Covid-19 restrictions, the 2 day symposium … Read more
Left to right: Micheline Sanderson; Gerald Tegha; Shivani Sud; Maganizo Chagomerana Not pictured: John Chapola; Mako Mulongo Lineberger Comprehensive Cancer Center (LCCC)/UNC Project Malawi Cancer Program Pilot Grant: The UNC Project Malawi Cancer Program has awarded three grants as part of the Mentored Pilot Grant Program funded by the UNC Lineberger Comprehensive Cancer Center (LCCC). … Read more
A team of researchers led by UNC Project-Malawi has received a one-year, $500,000 grant to build clinical and research capacity in Malawi to better diagnose and treat children with sickle cell disease. The funding is a joint award from the NIH’s National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases. … Read more
Since 2012, the University of North Carolina at Chapel Hill, Johns Hopkins University, Morehouse School of Medicine, and Tulane University have offered exceptional global public health training through the UJMT Fogarty Global Health Fellowship program, funded by the Fogarty International Center within the National Institutes of Health. This consortium brings together four top-ranked universities and … Read more
A team of UNC researchers are partnering with colleagues at four institutions in Africa to study HIV-associated malignancies. With a five-year, $6-million grant from the NIH’s National Cancer Institute, the research consortium will look at screening and diagnosing innovations for three cancers common to people with HIV: Kaposi sarcoma, cervical cancer, and lymphoma.
Our dear friend, Dr. Peter Kazembe, a Malawian colleague, pediatrician and adjunct professor of medicine with the University of North Carolina’s Institute for Global Health and Infection Diseases, died on August 11, 2020 at the age of 65 while receiving treatment for cancer in South Africa. He is survived by wife; Hilda, and three grown … Read more
University of North Carolina’s Kate Westmoreland, MD, has been amazed and excited by a surge of support for her work to improve treatment for adolescents and young adults with Burkitt lymphoma in Malawi, a country in Sub-Saharan Africa where this type of blood cancer is more common and deadly than in the United States. Westmoreland recently … Read more